Pfizer Says FDA Approves VELSIPITY For Adults With Moderately To Severely Active Ulcerative Colitis

RTTNews | 246 days ago
Pfizer Says FDA Approves VELSIPITY For Adults With Moderately To Severely Active Ulcerative Colitis

(RTTNews) - Pfizer Inc. (PFE) announced Friday that the U.S. Food and Drug Administration (FDA) has approved VELSIPITY (etrasimod) for adults with moderately to severely active ulcerative colitis (UC).

VELSIPITY is an oral, once-daily, selective sphingosine-1-phosphate (S1P) receptor modulator that selectively binds with S1P receptor subtypes 1, 4, and 5. The approved recommended dose for VELSIPITY is 2 mg.

The U.S. FDA approval was based on results from the ELEVATE UC Phase 3 registrational program (ELEVATE UC 52 and ELEVATE UC 12 pivotal trials). The program evaluated the safety and efficacy of VELSIPITY 2 mg once-daily on clinical remission in UC patients who had previously failed or were intolerant to at least one conventional, biologic, or Janus kinase (JAK) inhibitor therapy.

Nearly two-thirds of patients in ELEVATE UC 52 and ELEVATE UC 12 were naïve to biologic or JAK inhibitor therapy, and these studies were also the only studies for advanced therapies for ulcerative colitis to include patients with isolated proctitis.

Both studies achieved all primary and key secondary efficacy endpoints, with a favorable safety profile consistent with previous studies of VELSIPITY.

UC is a chronic and often debilitating condition1 that affects an estimated 1.25 million people in the U.S.

For More Such Health News, visit rttnews.com

read more
Pfizer's Hospira Recalls Select Hydrochloride Injection Carpuject Units

Pfizer's Hospira Recalls Select Hydrochloride Injection Carpuject Units

Hospira, Inc., affiliated to dug major Pfizer Inc., is recalling select lots of Buprenorphine Hydrochloride Injection Carpuject Units and Labetalol Hydrochloride Injection Carpuject Units, according to the U.S. Food and Drug Administration. The recall was initiated due to the potential for incomplete crimp seals. The company has received one customer complaint for one leaking unit.
RTTNews | 23 days ago
Amazon, Microsoft, Pfizer To Invest Billions In French Projects

Amazon, Microsoft, Pfizer To Invest Billions In French Projects

Major companies, including Amazon.com Inc., Microsoft Corp., Morgan Stanley, Pfizer and others, have announced around 15 billion euros or $16.2 billion worth foreign investments in France as part of the country's annual 'Choose France' business summit, reports said. French President Emmanuel Macron kicks off the summit of 180 CEOs and executives on Monday, aiming to showcase foreign investment.
RTTNews | 33 days ago
Pfizer Boost FY24 Adj. EPS Outlook - Update

Pfizer Boost FY24 Adj. EPS Outlook - Update

While reporting financial results for the first quarter, drug major Pfizer Inc. (PFE) raised its adjusted earnings guidance for the full-year 2024, while maintaining annual revenue outlook.
RTTNews | 45 days ago
Pfizer Closes $43 Bln All-cash Acquisition Of Seagen

Pfizer Closes $43 Bln All-cash Acquisition Of Seagen

Pfizer Inc. (PFE) announced Thursday the successful completion of its acquisition of biotechnology company Seagen Inc. (SGEN). Pfizer completed its acquisition of all outstanding common stock of Seagen for $229 in cash per share, for a total enterprise value of approximately $43 billion.
RTTNews | 184 days ago
Pfizer Reaffirms FY23 Outlook - Update

Pfizer Reaffirms FY23 Outlook - Update

While reporting financial results for the third quarter, drug major Pfizer Inc. (PFE) reaffirmed its adjusted earnings and revenue guidance for the full-year 2023.
RTTNews | 228 days ago
Pfizer's Hospira Recalls Sodium Bicarbonate, Lidocaine HCl Injections

Pfizer's Hospira Recalls Sodium Bicarbonate, Lidocaine HCl Injections

Hospira, Inc., owned by drug major Pfizer Inc., is recalling certain Sodium Bicarbonate and Lidocaine HCl Injections citing the potential for presence of glass particulate matter, the U.S. Food and Drug Administration said. The recall involves 4.2% Sodium Bicarbonate Injection, USP, 5 mEq/10mL vial; 1% Lidocaine HCl Injection, USP, 50 mg/5mL vial; and 2% Lidocaine HCl Injection, USP, 100 mg/5mL.
RTTNews | 256 days ago
CDC Recommends Updated Pfizer, Moderna COVID-19 Vaccine

CDC Recommends Updated Pfizer, Moderna COVID-19 Vaccine

The Centers for Disease Control and Prevention or CDC has recommended everyone 6 months and older to get an updated COVID-19 vaccine ahead of the virus season this fall and winter. The agency expects the updated COVID-19 vaccines from Pfizer-BioNTech and Moderna, which was approved by the U.S. Food and Drug Administration earlier this week, to be available later this week.
RTTNews | 276 days ago